ImmuCell Corporation (ICCC)
NASDAQ: ICCC · Real-Time Price · USD
8.36
+0.36 (4.44%)
At close: Apr 24, 2026, 4:00 PM EDT
8.21
-0.14 (-1.74%)
After-hours: Apr 24, 2026, 5:01 PM EDT
ImmuCell Employees
ImmuCell had 73 employees as of December 31, 2025. The number of employees decreased by 2 or -2.67% compared to the previous year.
Employees
73
Change
-2
Growth
-2.67%
Revenue / Employee
$378,687
Profits / Employee
-$14,247
Market Cap
75.59M
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| TScan Therapeutics | 142 |
| Fortress Biotech | 78 |
| OnKure Therapeutics | 45 |
| BeyondSpring | 44 |
| PDS Biotechnology | 24 |
| iBio, Inc. | 20 |
| ImageneBio | 15 |
| Spruce Biosciences | 8 |
ICCC News
- 11 days ago - ImmuCell Bolsters its Innovation Strategy with Appointments of Dr. Gilles Guillemette and Dr. Anthony DiMarco to the Board, and Moves to a Smaller Board of Independent Directors - GlobeNewsWire
- 16 days ago - ImmuCell Announces a 28.4% Increase in Product Sales in Q1 of 2026, based on Preliminary, Unaudited Sales Results - GlobeNewsWire
- 5 weeks ago - ImmuCell Appoints Former Elanco Animal Health Board Member Kathy Turner to Board - GlobeNewsWire
- 7 weeks ago - ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2025 - GlobeNewsWire
- 2 months ago - ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2025 - GlobeNewsWire
- 3 months ago - ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year of 2025 - GlobeNewsWire
- 3 months ago - ImmuCell to Conduct Conference Call with Investors to Discuss Strategic Change in Focus - GlobeNewsWire
- 4 months ago - ImmuCell Announces Strategic Focus on First Defense® After Receiving an FDA Incomplete Letter for Re-Tain® - GlobeNewsWire